Modern pharmacotherapies for type 2 diabetes mellitus.
CME CreditsThe National Medical Association (NMA) is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education (CME) for physicians.Readers:NMA certifies that when CME material is used as directed it meets the criteria for 2 hours of credit in Category I toward the NMA Physician Achievement Award (PAA) or American Medical Association Physician's Recognition Award (PRA).Each physician should claim only those hours of credit that the physician actually spent in the educational activity. Estimated time for reading the text and taking the CME quiz is approximately 2 hours. The NMA will not maintain any records on individual performance.Physician readers will receive 2 category I credits upon correctly answering a minimum of 70% of the CME questions at the end of this CME article. Physician readers must send the answers to JNMA/CME, 1012 Tenth St., NW, Washington, DC 20001. Answers to the CME questions accompanying this article must be marked by September 25, 2001.Authors:The first or second author of articles published in the Journal of the National Medical Association may claim Category I credit for the NMA PAA or the American Medical Association PRA by including a reprint of the article's first page as part of the PRA or PAA application.


CONCLUSIONS
PAA application can be obtained by calling NMA's CME office at (202) 347-1895, ext. 241. PRA application can be found by visiting http://www.ama-assn.org/med-sci/pra/prahdr.htm.
Hsia
S H
SH
Division of Endocrinology and Metabolism, Charles R. Drew University of Medicine and Science, Los Angeles, California 90059, USA.
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004502:Education, Medical, Continuing; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*
D007004:Hypoglycemic Agents